Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (3)

Search Parameters:
Authors = Amin Abyad

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
16 pages, 318 KiB  
Review
Breast Cancer in the Arabian Gulf Countries
by Humaid O. Al-Shamsi, Nadia Abdelwahed, Amin Abyad, Ibrahim Abu-Gheida, Mehdi Afrit, Tasneem Abu ElFuol, Ryad Alasas, Bilal Lababidi, Prasanta Dash, Mudhasir Ahmad, Norbert W. Dreier, Urfan ul Haq, Thanda Lucy Ann Joshua, Sonia Otsmane, Anwar Al-Nouri, Aydah Al-Awadhi, Syed Hammad Tirmazy, Faisal Alterkait, Shimaa Elsabae, Nyla Khan, Nehad Kazim Albastaki, Yoginee Sonawane, Mohammed Jouda, Frea Perdawood, Faryal Iqbal and Hassan Jaafaradd Show full author list remove Hide full author list
Cancers 2023, 15(22), 5398; https://doi.org/10.3390/cancers15225398 - 14 Nov 2023
Cited by 8 | Viewed by 3921
Abstract
Breast cancer stands as the prevailing malignancy across all six Gulf Cooperation Council (GCC) nations. In this literature review, we highlighted the incidence and trend of breast cancer in the GCC. Most of the studies reported a consistent increase in breast cancer incidence [...] Read more.
Breast cancer stands as the prevailing malignancy across all six Gulf Cooperation Council (GCC) nations. In this literature review, we highlighted the incidence and trend of breast cancer in the GCC. Most of the studies reported a consistent increase in breast cancer incidence over the past decades, which was particularly attributed to the adoption of a Westernized lifestyle in the region and the implications of emerging risk factors and other environmental and societal factors, the increase in screening uptake, as well as the improvement in data collection and reporting in the GCC. The data on breast cancer risk factors in the GCC were limited. In this geographic region, breast cancer frequently manifests with distinctive characteristics, including an early onset, typically occurring before the age of 50; an advanced stage at presentation; and a higher pathological grade. Additionally, it often exhibits more aggressive features such as human epidermal growth factor receptor 2 (HER2) positivity or the presence of triple-negative (TN) attributes, particularly among younger patients. Despite the growing body of literature on breast cancer in the GCC, data pertaining to survival rates are, regrettably, meager. Reports on breast cancer survival rates emanating from the GCC region are largely confined to Saudi Arabia and the United Arab Emirates (UAE). In the UAE, predictive modeling reveals 2-year and 5-year survival rates of 97% and 89%, respectively, for the same period under scrutiny. These rates, when compared to Western counterparts such as Australia (89.5%) and Canada (88.2%), fall within the expected range. Conversely, Saudi Arabia reports a notably lower 5-year survival rate, standing at 72%. This disparity in survival rates underscores the need for further research directed toward elucidating risk factors and barriers that hinder early detection and screening. Additionally, there is a pressing need for expanded data reporting on survival outcomes within the GCC. In sum, a more comprehensive and nuanced understanding of breast cancer dynamics in this region is imperative to inform effective strategies for prevention, early detection, and improved patient outcomes. Full article
(This article belongs to the Section Cancer Epidemiology and Prevention)
15 pages, 544 KiB  
Review
A Proposal for a National Cancer Control Plan for the UAE: 2022–2026
by Humaid O. Al-Shamsi, Amin M. Abyad and Saeed Rafii
Clin. Pract. 2022, 12(1), 118-132; https://doi.org/10.3390/clinpract12010016 - 17 Feb 2022
Cited by 17 | Viewed by 5910
Abstract
The United Arab Emirates (UAE) is one of the fastest growing economies with consequent increase in non-communicable diseases including cancer. The number of reported cases and mortality have been increasing in the UAE over the years, despite screening and early detection efforts which [...] Read more.
The United Arab Emirates (UAE) is one of the fastest growing economies with consequent increase in non-communicable diseases including cancer. The number of reported cases and mortality have been increasing in the UAE over the years, despite screening and early detection efforts which appear to be far from target coverage of the intended population. In this work, we highlight key elements of a proposed national cancer control plan for the UAE. The plan is still a work in progress and has not yet been officially adopted. A comprehensive and effective control plan requires accurate data, a reliable cancer registry, and periodic monitoring and evaluation. The UAE cancer control plan is being prepared in line with the WHO and EMRO framework, with defined objectives and goals. The objectives are to combat cancer, reduce incidence, control mortality, and improve outcomes and quality of life for cancer patients. There is also a focus on improving public health education, prevention, early detection, prompt diagnosis, treatment facilitation, continuity of care, performance evaluation, training of workforce, and research. Full article
7 pages, 634 KiB  
Review
Establishment of the First Comprehensive Adult and Pediatric Hematopoietic Stem Cell Transplant Unit in the United Arab Emirates: Rising to the Challenge
by Humaid O. Al-Shamsi, Amin Abyad, Panayotis Kaloyannidis, Amro El-Saddik, Ahmad Alrustamani, Ibrahim Abu Gheida, Azzam Ziade, Norbert W. Dreier, Urfan Ul-Haq, Thanda Lucy Ann Joshua, Abdul Rahman El Kinge, Ritika Coelho, Dima Ibrahim, Mehdi Afrit, Bilal Al-Lababidi, Zainul Aabideen, Mayur Sabhani, Rakeshkumar Shah, Ghaith Makhlouf, Lana Iskandaerani, Faryal Iqbal, Shiny Narayanan, Mohammed Ameen, Theresa Morrison, Charbel Khalil and Kayane Mheidlyadd Show full author list remove Hide full author list
Clin. Pract. 2022, 12(1), 84-90; https://doi.org/10.3390/clinpract12010010 - 28 Jan 2022
Cited by 6 | Viewed by 5623
Abstract
Hematopoietic stem cell transplantation (HSCT) is increasingly indicated for various malignant and non-malignant diseases. In the United Arab Emirates (UAE), patients that could benefit from the procedure commonly need to seek medical care abroad in view of the lack of a comprehensive HSCT [...] Read more.
Hematopoietic stem cell transplantation (HSCT) is increasingly indicated for various malignant and non-malignant diseases. In the United Arab Emirates (UAE), patients that could benefit from the procedure commonly need to seek medical care abroad in view of the lack of a comprehensive HSCT facility that could offer the full spectrum of interventions and monitoring protocols. This comes with considerable challenges related to coverage and logistics of travel. It also limits the continuity of clinical care, and presents inconvenience to patients who come from a different cultural background. In this article, we share our experiences and lessons learned during the establishment of the first comprehensive adult and pediatric HSCT unit in the UAE that is designed to cater for local citizens and residents, as well as neighboring countries facing similar availability challenges. Full article
Show Figures

Figure 1

Back to TopTop